Fate Therapeutics Inc (FATE)

EBITDA Margin

-1334.01%

Quarterly · Period ending:

FATE logo

FATE EBITDA Margin

Latest reported-1334.01%
FATE Quarterly EBITDA Margin (-662.31% → -1334.01%)
High-resolution chart · PNG

FATE ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-1,334.0058%
-2,178.214%
-2,141.0519%
-1,667.0304%
-1,614.6827%
-2,104.8496%
-2,268.7097%
-1,401.1386%
-497.7259%
-2,243.2727%
-2,341.1098%
-2,079.7325%
-5,175.6699%
-24.9067%
-116.1534%
-536.4795%
-394.3231%
-341.7454%
-389.0972%
-293.7715%
-402.3785%
-406.13%
-204.693%
-406.3773%
-511.6011%
-1,343.4195%
-968.6296%
-1,054.8374%
-799.645%
-718.655%
-919.3257%
-1,563.6452%
-1,844.9854%
-1,309.6491%
-1,148.4907%
-980.7018%
-896.8811%
-940.0195%
-721.3242%
-792.7875%
-756.6699%
-581.6188%
-622.8625%
-598.538%
-2,144.6809%
0%
0%
0%
0%
0%
491.5551%
-2,396.1722%
-1,827.931%
-697.2458%
-604.0435%
-662.3106%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.